KRAS Inhibitor

general

7

Centers

0

Active Trials

$15M

Cancer Funding

Specific Cancer Types(1)

NameCenters
KRAS G12C Inhibitor—

Top Centers for KRAS Inhibitor(7)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
High-Volume Research Center
72.1
2
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
Active Research Program
67.1
3
University of Cincinnati Cancer CenterCincinnati, OH
Active Research Program
62.1
4
Sandra and Edward Meyer Cancer Center at Weill Cornell MedicineNew York, NY
Active Research Program
57.1
5
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY
NCI Comprehensive
Active Research Program
52.1
6
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
47.1
7
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
Active Research Program
42.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →